Binding and in vitro modulation of human epidermal Langerhans cell functions by substance P

Archives of Dermatological Research

Volumn 289, Issue 5, 1997, Pages 285-291

  Staniek, Véronique ^a   Misery, Laurent ^a   Péguet Navarro, Josette ^a   Abello, Jacques ^a   Doutremepuich, Jean Daniel ^b   Claudy, Alain ^a   Schmitt, Daniel ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b Galderma R and D   (France)

Author keywords

Epidermal Langerhans cells; Immunomodulation; Substance P; Substance P receptors

Indexed keywords

RADIOLIGAND; SUBSTANCE P; SUBSTANCE P RECEPTOR;

ANTIGEN PRESENTATION; ARTICLE; CELL FUNCTION; CELL SUSPENSION; CELL VIABILITY; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EPIDERMIS CELL; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; LANGERHANS CELL; LIGAND BINDING; LYMPHOCYTE; MACROPHAGE; MIXED LYMPHOCYTE REACTION; NORMAL HUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RECEPTOR BINDING; T LYMPHOCYTE;

BINDING, COMPETITIVE; CELL COUNT; CELLS, CULTURED; EPIDERMIS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; KINETICS; LANGERHANS CELLS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; PROTEIN BINDING; RECEPTORS, NEUROKININ-1; SUBSTANCE P; T-LYMPHOCYTES;

EID: 0030836380     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050194     Document Type: Article

References (42)

1. Felten LD, Felten YS, Ackerman DK, Bellinger DL, Kelly SM, Carlson SL, Livnat S (1990) Neuroendocrine-immune network. In: Freier S (ed), CRC. Boca Raton, p 9
2. Bernstein J (1991) In: Goldsmith LA (ed) Physiology, biochemistry and molecular biology of the skin, 2nd edn. Oxford University Press, Oxford, p 816
3. Pernow B (1985) Role of tachykinins in neurogenic inflammation. J Immunol 135 : 812s-815s
4. Olsuka M, Kansishi S (1983) Substance P - the first peptide neurotransmitter. Trends Neurosci 6 : 317-319
5. Maggi CA, Patacchini R, Rovero P, Giachetti A (1993) Tachykinin receptors and tachykinin receptor antagonists. J Auton Pharmacol 13 : 23-29
6. Krause J, Takeda Y, Hershey A (1992) Structure, functions, and mechanisms of substance P receptor action. J Invest Dermatol 98 : 2S-7S
7. Payan DG, Brewster DR, Missirian-Bastien A, Goetzl EJ (1984) Substance P recognition by a subset of human T-lymphocytes. J Clin Invest 74 : 1532-1539
8. McGillis J, Mitsubashi M, Payan DG (1990) Immunomodulation by tachykinin neuropeptides. Ann NY Aca Sci 594 : 85-94
9. Gosco C, Potier E, Manzini S, Szallasi A (1994) Comparison of tachykinin NK (1) recpetors in human 1M9 and U373-MG cells, using antagonist (FK888, (+/-)-CP-96,345, and RP-67 580) Binding. Eur J Pharmacol 254 : 221-227
10. Payan DG, Brewster DR, Goetzl EJ (1984) Stereospecific receptors for substance P on cultured human IM-9 lymphoblasts. J Immunol 133 : 3260-3265
11. Payan DG, McGillis JP, Organist ML (1986) Binding characteristics and affinity labeling of protein constituents of the human IM-9 lymphoblast receptor for substance P. J Immunol 261 : 14321-14329
12. Wagner F, Fink R, Hart R, Dancygier H (1987) Substance P enhances interferon-γ production by human peripheral blood mononuclear cells. Regul Pept 19 : 355-364
13. Dalsgaard C, Jonsson C, Hökfelt T, Cuello AC (1982) A localization of substance P-immunoreactive nerve fibers in the human digital skin. Experientia 39 : 1018-1020
14. Wallengren J, Hakanson R (1987) Effects of substance P, neurokinin A and calcitonin gene-related peptide in human skin and their involvement in sensory nerve-mediated responses. Eur J Pharmacol 143 : 267-273
15. Eedy DJ, Shaw C, Johnston CF, Buchanan KD (1994) The regional distribution of neuropeptides in human skin as assessed by radioimmunoassay and high-performance liquid chromatography. Clin Exp Dermatol 19 : 463-472
16. Anand P, Spingall DR, Blank MA, Sellu D, Polak JM, Boom SR (1991) Neuropeptides in skin disease: increased VIP in eczema and psoriasis but not axillary hyperhydrosis. Br J Dermatol 124 : 547-549
17. Fantini F, Pincelli C, Romualdi P, Donatini A, Giannetti A (1992) Substance P levels are decreased in lesional skin of atopic dermatitis. Exp Dermatol 1 : 126-128
18. Pincelli C, Fantini F, Massimi P, Girolomoni G, Seidenari S, Giannetti A (1990) Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study. Br J Dermatol 122 : 745-750
19. Eedy DJ, Johnston CF, Shaw C, Buchanan KD (1991) Neuropeptides in psoriasis: an immunocytochemical and radioimmunoassay study. J Invest Dermatol 96 : 434-438
20. Giannetti A, Girolomoni G (1989) Skin reactivity to neuropeptides in atopic dermatitis. Br J Dermatol 121 : 681-688
21. Viac J, Guéniche A, Doutremepuich JD, Reichert U, Claudy A, Schmitt D (1996) Substance P and keratinocyte activation markers: an in vitro approach. Arch Dermatol Res 288 : 85-90
22. Péguet-Navarro J, Moulon C, Schmitt D (1994) The antigen presenting capacity of human epidermal Langerhans cells. Cell Mol Biol 40 : 15-20
23. Pincelli C, Fantini F, Giardino L, Zanni M, Calza L, Sevignani C, Giannetti A (1993) Autoradiographic detection of substance P receptors in normal and psoriatic skin. J Invest Dermatol 101 : 301-304
24. Arenberger P, Leder RO, Abraham A, Chang JK, Farber EM (1995) Substance P binding in normal neonatal foreskin. Br J Dermatol 132 : 54-58
25. Kemeny L, Vonrestorff B, Michel G, Ruzicka T (1994) Specific binding and lack of growth-promoting activity of substance P in cultured human keratinocytes. J Invest Dermatol 103 : 605-606
26. Rameshwar P, Ganea D, Gascon P (1993) In vitro stimulatory effect of SP on hematopoiesis. Blood 81 : 391-398
27. Rameshwar P, Gascon P (1994) Regulation of substance-P (SP)-like receptors in CD34+ cells by cytokines and neurotrophic factors. FASEB J 8 : 248
28. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J (1992) Human dendritic Langerhans cells generated in vitro from CD34(+) progenitors can prime naive CD4(+) T cells and process soluble antigen. Nature 360 : 258-264
29. Hosoi J, Murphy GF, Egan CL, Lerner EA, Grabbe S, Asahina A, Granstein RD (1993) Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 363 : 159-163
30. Shanahan F, Denburg JA, Fux J (1985) Mast cell heterogeneity: effects of neuroenteric peptides on histamine release. J Immunol 135 : 1331-1337
31. Gaudillère A, Misery L, Souchier C, Claudy A, Schmitt D (1996) Intimate associations between PGP 9.5-positive nerve fibers and Langerhans cells. Br J Dermatol 135 : 343-344
32. Guard S, Watson SP (1991) Tachykinin receptor types: classification and membrane signalling mechanisms. Neurochem Int 18 : 149-165
33. Kavelaars A, Jeurissen F, Frijtag Drabbe Künsel J, Rijkers GR, Heijnen CJ (1993) Substance P induces a rise in intracellular calcium concentration in human T lymphocytes in vitro: evidence of a receptor-independent mechanism. J Neuroimmunol 42 : 61-70
34. Asahina A, Hosoi J, Beissert S, Stratigos A, Granstein RD (1995) Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide. J Immunol 154 : 3056-3061
35. Asahina A, Moro O, Hosoi J, Lerner EA, Xu S, Takshima A, Granstein RD (1995) Specific induction of cAMP in Langerhans cells by calcitonin gene-related peptide: relevance to functional effects. Proc Natl Acad Sci (USA) 92 : 8323-8327
36. Björklund H, Dalsgaard CJ, Jonsson CE, Hermansson A (1986) Sensory and autonomic innervation of non-hairy and hairy human skin. Cell Tissue Res 243 : 51-55
37. Payan DG, Brewster DR, Goeltz EJ (1983) Specific stimulation of human T lymphocytes by substance P. J Immunol 131 : 1613-1615
38. Reusch MK, Karasek MA, Nickoloff BJ (1988) Effect of neuropeptides present in skin on the proliferation of human peripheral blood mononuclear cells and T cells. Arch Dermatol Res 280 : 279-281
39. Nio DA, Moylan RN, Roche JK (1993) Modulation of T lymphocyte function by neuropeptides. J Immunol 150 : 5281-5288
40. Liping Z, Dan C, Shuzhen Z, Shilian L (1984) Observation of the effect of substance P on human T and B lymphocyte proliferation, Immunol Commun 13 : 457-164
41. Stewart MJ, Emery DL, McClure SJ (1994) Effects of four neuropeptides on lymphocytes from sheep. Regi Immunol 6 : 264-269
42. Carucci JA, Auci DL, Herrick CA, Durkin HG (1995) Neuropeptide-mediated regulation of hapten-specific IgE responses in mice I. Substance p-mediated isotype-specific suppression of BPO-specific IgE antibody-forming cell responses induced in vivo and in vitro. J Leukoc Biol 57 : 110-115